Avior Genomics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -3141.51%
- Ebitda -62255.91%
- Net Worth -732.39%
- Total Assets 0.11%
About Avior Genomics
Avior Genomics Private Limited (AGPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 March 2021 (Three years and ten months 13 days old ). Its registered office is in Bellary, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Riken Gala and Sachin Rajpurohit serve as directors at the Company.
Company Details
- Location
Bellary, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100KA2021PTC145382
- Company No.
145382
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Avior Genomics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Rajpurohit  | Director | 16-Mar-2021 | Current |
| Riken Gala | Director | 16-Mar-2021 | Current |
Financial Performance of Avior Genomics.
Avior Genomics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 3141.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 732.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avior Genomics?
Unlock access to Avior Genomics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Velar Health Private LimitedRiken Gala and Sachin Rajpurohit are mutual person
Valnizen Healthcare Private LimitedRiken Gala is a mutual person
Nivian Pharma LlpRiken Gala is a mutual person
Kap Advisory Private LimitedRiken Gala and Sachin Rajpurohit are mutual person
Clara Ventures LlpRiken Gala is a mutual person
- Avior Mines And Minerals Private Limited
Riken Gala and Sachin Rajpurohit are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avior Genomics?
Avior Genomics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avior Genomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avior Genomics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.